{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T23:51:28Z","timestamp":1768607488579,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-31266-w","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T08:35:33Z","timestamp":1765528533000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ustekinumab may have therapeutic effects on autoimmune thyroid disease"],"prefix":"10.1038","volume":"16","author":[{"given":"Suleyman Sami","family":"Guzel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet Numan","family":"Demir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tugce","family":"Eskazan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Ibrahim","family":"Hatemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1089-623X","authenticated-orcid":false,"given":"Mustafa Sait","family":"Gonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"issue":"2","key":"31266_CR1","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.autrev.2014.10.016","volume":"14","author":"A -Antonelli","year":"2015","unstructured":"-Antonelli, A., Ferrari, S. M., Corrado, A., Di Domenicantonio, A. & Fallahi, P. Autoimmune thyroid disorders. Autoimmun. Rev. 14 (2), 174\u2013180. https:\/\/doi.org\/10.1016\/j.autrev.2014.10.016 (2015).","journal-title":"Autoimmun. Rev."},{"issue":"5","key":"31266_CR2","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1530\/eje.0.1500605","volume":"150","author":"MF -Prummel","year":"2004","unstructured":"-Prummel, M. F., Strieder, T. & Wiersinga, W. M. The environment and autoimmune thyroid diseases. Eur. J. Endocrinol. 150 (5), 605\u2013618. https:\/\/doi.org\/10.1530\/eje.0.1500605 (2004).","journal-title":"Eur. J. Endocrinol."},{"key":"31266_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cyto.2016.02.011","volume":"80","author":"C -Konca Degertekin","year":"2016","unstructured":"-Konca Degertekin, C. et al. Circulating Th17 cytokine levels are altered in hashimoto\u2019s thyroiditis. Cytokine 80, 13\u201317. https:\/\/doi.org\/10.1016\/j.cyto.2016.02.011 (2016).","journal-title":"Cytokine"},{"issue":"4","key":"31266_CR4","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1365-2265.2004.02085.x","volume":"61","author":"AP -Weetman","year":"2004","unstructured":"-Weetman, A. P. Cellular immune responses in autoimmune thyroid disease. Clin. Endocrinol. (Oxf). 61 (4), 405\u2013413. https:\/\/doi.org\/10.1111\/j.1365-2265.2004.02085.x (2004).","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"4","key":"31266_CR5","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1507\/endocrj.ej13-0484","volume":"61","author":"RM -Ruggeri","year":"2014","unstructured":"-Ruggeri, R. M. et al. Serum interleukin-23 (IL-23) is increased in hashimoto\u2019s thyroiditis. Endocr. J. 61 (4), 359\u2013363. https:\/\/doi.org\/10.1507\/endocrj.ej13-0484 (2014).","journal-title":"Endocr. J."},{"issue":"2","key":"31266_CR6","doi-asserted-by":"publisher","first-page":"101773","DOI":"10.1016\/j.beem.2023.101773","volume":"37","author":"SM -Ferrari","year":"2023","unstructured":"-Ferrari, S. M. et al. Chemokines in thyroid autoimmunity. Best Pract. Res. Clin. Endocrinol. Metab. 37 (2), 101773. https:\/\/doi.org\/10.1016\/j.beem.2023.101773 (2023).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"12 Suppl","key":"31266_CR7","first-page":"5S","volume":"92","author":"RB -Sartor","year":"1997","unstructured":"-Sartor, R. B. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am. J. Gastroenterol. 92 (12 Suppl), 5S\u201311S (1997).","journal-title":"Am. J. Gastroenterol."},{"issue":"9","key":"31266_CR8","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1007\/s11605-011-1588-5","volume":"15","author":"D -Subasinghe","year":"2011","unstructured":"-Subasinghe, D., Nawarathna, N. M. & Samarasekera, D. N. Disease characteristics of inflammatory bowel disease (IBD): findings from a tertiary care centre in South Asia. J. Gastrointest. Surg. 15 (9), 1562\u20131567. https:\/\/doi.org\/10.1007\/s11605-011-1588-5 (2011).","journal-title":"J. Gastrointest. Surg."},{"issue":"1","key":"31266_CR9","first-page":"13","volume":"90","author":"G -Messina","year":"1999","unstructured":"-Messina, G., Viceconti, N. & Trinti, B. Valutazione clinica ed ecografica Della funzione e Della struttura tiroidee in pazienti Con Malattia infiammatoria cronica intestinale [The clinical and echographic assessment of thyroid function and structure in patients with a chronic inflammatory intestinal disease]. Recenti Prog Med. 90 (1), 13\u201316 (1999).","journal-title":"Recenti Prog Med."},{"issue":"1","key":"31266_CR10","first-page":"43","volume":"21","author":"K -Neubauer","year":"2012","unstructured":"-Neubauer, K. & Wo\u017aniak-Stolarska, B. Ultrasonographic assessment of the thyroid gland structure in inflammatory bowel disease patients. Adv. Clin. Exp. Med. 21 (1), 43\u201346 (2012).","journal-title":"Adv. Clin. Exp. Med."},{"key":"31266_CR11","doi-asserted-by":"publisher","first-page":"5187061","DOI":"10.1155\/2016\/5187061","volume":"2016","author":"T -Shizuma","year":"2016","unstructured":"-Shizuma, T. Concomitant thyroid disorders and inflammatory bowel disease: A literature review. Biomed. Res. Int. 2016, 5187061. https:\/\/doi.org\/10.1155\/2016\/5187061 (2016).","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"31266_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/apt.13847","volume":"45","author":"EJ -Mao","year":"2017","unstructured":"-Mao, E. J., Hazlewood, G. S., Kaplan, G. G., Peyrin-Biroulet, L. & Ananthakrishnan, A. N. Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in crohn\u2019s disease and ulcerative colitis. Aliment. Pharmacol. Ther. 45 (1), 3\u201313. https:\/\/doi.org\/10.1111\/apt.13847 (2017).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"31266_CR13","doi-asserted-by":"publisher","first-page":"1322054","DOI":"10.3389\/fimmu.2024.1322054","volume":"15","author":"W -Zhang","year":"2024","unstructured":"-Zhang, W., Zhong, G., Ren, X. & Li, M. Research progress of ustekinumab in the treatment of inflammatory bowel disease. Front. Immunol. 15, 1322054. https:\/\/doi.org\/10.3389\/fimmu.2024.1322054 (2024). Published 2024 Feb 22.","journal-title":"Front. Immunol."},{"issue":"9573","key":"31266_CR14","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/S0140-6736(07)60750-8","volume":"369","author":"DC -Baumgart","year":"2007","unstructured":"-Baumgart, D. C. & Carding, S. R. Inflammatory bowel disease: cause and immunobiology. Lancet 369 (9573), 1627\u20131640. https:\/\/doi.org\/10.1016\/S0140-6736(07)60750-8 (2007).","journal-title":"Lancet"},{"issue":"5","key":"31266_CR15","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1007\/s00330-004-2238-z","volume":"14","author":"AJ -van der Molen","year":"2004","unstructured":"-van der Molen, A. J., Thomsen, H. S., Morcos, S. K. & Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Effect of iodinated contrast media on thyroid function in adults. Eur. Radiol. 14 (5), 902\u2013907. https:\/\/doi.org\/10.1007\/s00330-004-2238-z (2004).","journal-title":"Eur. Radiol."},{"issue":"1","key":"31266_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.7326\/0003-4819-101-1-28","volume":"101","author":"E -Martino","year":"1984","unstructured":"-Martino, E. et al. Environmental iodine intake and thyroid dysfunction during chronic Amiodarone therapy. Ann. Intern. Med. 101 (1), 28\u201334. https:\/\/doi.org\/10.7326\/0003-4819-101-1-28 (1984).","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"31266_CR17","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1089\/105072502760143908","volume":"12","author":"DD -Ascheim","year":"2002","unstructured":"-Ascheim, D. D. & Hryniewicz, K. Thyroid hormone metabolism in patients with congestive heart failure: the low Triiodothyronine state. Thyroid 12 (6), 511\u2013515. https:\/\/doi.org\/10.1089\/105072502760143908 (2002).","journal-title":"Thyroid"},{"issue":"2","key":"31266_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1600-0676.1991.tb00495.x","volume":"11","author":"GP -Bianchi","year":"1991","unstructured":"-Bianchi, G. P. et al. Thyroid gland size and function in patients with cirrhosis of the liver. Liver 11 (2), 71\u201377. https:\/\/doi.org\/10.1111\/j.1600-0676.1991.tb00495.x (1991).","journal-title":"Liver"},{"issue":"2","key":"31266_CR19","first-page":"7","volume":"12","author":"E -Dilek","year":"2016","unstructured":"-Dilek, E. & Tutunculer, F. \u0130yot Yetersizli\u011fi Hastal\u0131klar\u0131nda D\u00fcnyada ve T\u00fcrkiye\u2019de G\u00fcncel durum. Turkiye Klinikleri Pediatr. Sciences-Special Top. 12 (2), 7\u201313 (2016).","journal-title":"Turkiye Klinikleri Pediatr. Sciences-Special Top."},{"issue":"2","key":"31266_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1001\/jama.2019.9052","volume":"322","author":"B -Biondi","year":"2019","unstructured":"-Biondi, B., Cappola, A. R. & Cooper, D. S. Subclinical hypothyroidism: A review. JAMA 322 (2), 153\u2013160. https:\/\/doi.org\/10.1001\/jama.2019.9052 (2019).","journal-title":"JAMA"},{"issue":"5854","key":"31266_CR21","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1136\/bmj.1.5854.657","volume":"1","author":"DC -Evered","year":"1973","unstructured":"-Evered, D. C., Ormston, B. J., Smith, P. A., Hall, R. & Bird, T. Grades of hypothyroidism. Br. Med. J. 1 (5854), 657\u2013662. https:\/\/doi.org\/10.1136\/bmj.1.5854.657 (1973).","journal-title":"Br. Med. J."},{"issue":"10","key":"31266_CR22","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1089\/thy.2016.0229","volume":"26","author":"DS -Ross","year":"2016","unstructured":"-Ross, D. S. et al. 2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid: Official J. Am. Thyroid Association. 26 (10), 1343\u20131421 (2016).","journal-title":"Thyroid: Official J. Am. Thyroid Association"},{"issue":"1","key":"31266_CR23","doi-asserted-by":"publisher","first-page":"234","DOI":"10.2214\/AJR.04.0816","volume":"186","author":"W -Shabana","year":"2006","unstructured":"-Shabana, W., Peeters, E. & De Maeseneer, M. Measuring thyroid gland volume: should we change the correction factor? AJR Am. J. Roentgenol. 186 (1), 234\u2013236. https:\/\/doi.org\/10.2214\/AJR.04.0816 (2006).","journal-title":"AJR Am. J. Roentgenol."},{"issue":"2","key":"31266_CR24","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1210\/jcem-56-2-260","volume":"56","author":"L -Heged\u00fcs","year":"1983","unstructured":"-Heged\u00fcs, L. et al. The determination of thyroid volume by ultrasound and its relationship to body weight, age, and sex in normal subjects. J. Clin. Endocrinol. Metab. 56 (2), 260\u2013263. https:\/\/doi.org\/10.1210\/jcem-56-2-260 (1983).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"31266_CR25","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00108-006-1598-7","volume":"47","author":"B -Braun","year":"2006","unstructured":"-Braun, B. & Blank, W. Sonographie der Schilddr\u00fcse und Nebenschilddr\u00fcsen [Ultrasonography of the thyroid and parathyroid gland]. Internist (Berl). 47 (7), 729\u2013747. https:\/\/doi.org\/10.1007\/s00108-006-1598-7 (2006).","journal-title":"Internist (Berl)"},{"issue":"11","key":"31266_CR26","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.7863\/ultra.32.11.1979","volume":"32","author":"A -Willms","year":"2013","unstructured":"-Willms, A. et al. Correlation between sonography and antibody activity in patients with Hashimoto thyroiditis. J. Ultrasound Med. 32 (11), 1979\u20131986. https:\/\/doi.org\/10.7863\/ultra.32.11.1979 (2013).","journal-title":"J. Ultrasound Med."},{"key":"31266_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3389\/fendo.2016.00057","volume":"7","author":"JW -Dietrich","year":"2016","unstructured":"-Dietrich, J. W. et al. Calculated parameters of thyroid homeostasis: emerging tools for differential diagnosis and clinical research. Front. Endocrinol. (Lausanne). 7, 57. https:\/\/doi.org\/10.3389\/fendo.2016.00057 (2016). Published 2016 Jun 9.","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"31266_CR28","doi-asserted-by":"publisher","unstructured":"Dietrich, J. W., Stachon, A., Antic, B., Klein, H. H. & Hering, S. The AQUA-FONTIS study: protocol of a multidisciplinary, cross-sectional and prospective longitudinal study for developing standardized diagnostics and classification of non-thyroidal illness syndrome. BMC Endocr. Disord. 8 (13). https:\/\/doi.org\/10.1186\/1472-6823-8-13 (2008). Published 2008 Oct 13.","DOI":"10.1186\/1472-6823-8-13"},{"issue":"6","key":"31266_CR29","first-page":"291","volume":"27","author":"GP -Bianchi","year":"1995","unstructured":"-Bianchi, G. P., Marchesini, G., Gueli, C. & Zoli, M. Thyroid involvement in patients with active inflammatory bowel diseases. Ital. J. Gastroenterol. 27 (6), 291\u2013295 (1995).","journal-title":"Ital. J. Gastroenterol."},{"key":"31266_CR30","doi-asserted-by":"publisher","first-page":"j2505","DOI":"10.1136\/bmj.j2505","volume":"357","author":"BL -Cohen","year":"2017","unstructured":"-Cohen, B. L. & Sachar, D. B. Update on anti-tumor necrosis factor agents and other new drugs for inflammatory bowel disease. BMJ 357, j2505. https:\/\/doi.org\/10.1136\/bmj.j2505 (2017). Published 2017 Jun 19.","journal-title":"BMJ"},{"issue":"4","key":"31266_CR31","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00296-012-2438-9","volume":"33","author":"F -Tarhan","year":"2013","unstructured":"-Tarhan, F., Or\u00fck, G., Niflio\u011flu, O. & Ozer, S. Thyroid involvement in ankylosing spondylitis and relationship of thyroid dysfunction with anti-TNF \u03b1 treatment. Rheumatol. Int. 33 (4), 853\u2013857. https:\/\/doi.org\/10.1007\/s00296-012-2438-9 (2013).","journal-title":"Rheumatol. Int."},{"issue":"1","key":"31266_CR32","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1189\/jlb.0606402","volume":"81","author":"K -Chen","year":"2007","unstructured":"-Chen, K., Wei, Y., Sharp, G. C. & Braley-Mullen, H. Decreasing TNF-alpha results in less fibrosis and earlier resolution of granulomatous experimental autoimmune thyroiditis. J. Leukoc. Biol. 81 (1), 306\u2013314. https:\/\/doi.org\/10.1189\/jlb.0606402 (2007).","journal-title":"J. Leukoc. Biol."},{"issue":"11","key":"31266_CR33","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1507\/endocrj.EJ18-0243","volume":"65","author":"SA -Paschou","year":"2018","unstructured":"-Paschou, S. A. et al. The effect of anti-TNF therapy on thyroid function in patients with inflammatory bowel disease. Endocr. J. 65 (11), 1121\u20131125. https:\/\/doi.org\/10.1507\/endocrj.EJ18-0243 (2018).","journal-title":"Endocr. J."},{"key":"31266_CR34","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3389\/fendo.2017.00179","volume":"8","author":"S -Bliddal","year":"2017","unstructured":"-Bliddal, S., Borresen, S. W. & Feldt-Rasmussen, U. Thyroid autoimmunity and function after treatment with biological antirheumatic agents in rheumatoid arthritis. Front. Endocrinol. (Lausanne). 8, 179. https:\/\/doi.org\/10.3389\/fendo.2017.00179 (2017). Published 2017 Jul 31.","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"8","key":"31266_CR35","doi-asserted-by":"publisher","first-page":"576","DOI":"10.2174\/138920211798120763","volume":"12","author":"K -Zaletel","year":"2011","unstructured":"-Zaletel, K. & Gaber\u0161\u010dek, S. Hashimoto\u2019s thyroiditis: from genes to the disease. Curr. Genomics. 12 (8), 576\u2013588. https:\/\/doi.org\/10.2174\/138920211798120763 (2011).","journal-title":"Curr. Genomics"},{"issue":"1","key":"31266_CR36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1530\/EJE-14-0147","volume":"171","author":"M -Rotondi","year":"2014","unstructured":"-Rotondi, M. et al. Serum negative autoimmune thyroiditis displays a milder clinical picture compared with classic hashimoto\u2019s thyroiditis. Eur. J. Endocrinol. 171 (1), 31\u201336. https:\/\/doi.org\/10.1530\/EJE-14-0147 (2014).","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"31266_CR37","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s40618-020-01477-1","volume":"44","author":"AP -Weetman","year":"2021","unstructured":"-Weetman, A. P. An update on the pathogenesis of hashimoto\u2019s thyroiditis. J. Endocrinol. Invest. 44 (5), 883\u2013890. https:\/\/doi.org\/10.1007\/s40618-020-01477-1 (2021).","journal-title":"J. Endocrinol. Invest."},{"issue":"5","key":"31266_CR38","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nri3661","volume":"14","author":"MF -Neurath","year":"2014","unstructured":"-Neurath, M. F. Cytokines in inflammatory bowel disease. Nat. Rev. Immunol. 14 (5), 329\u2013342. https:\/\/doi.org\/10.1038\/nri3661 (2014).","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"31266_CR39","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1053\/j.gastro.2021.07.042","volume":"161","author":"G -Rogler","year":"2021","unstructured":"-Rogler, G., Singh, A., Kavanaugh, A. & Rubin, D. T. Extraintestinal manifestations of inflammatory bowel disease: current Concepts, Treatment, and implications for disease management. Gastroenterology 161 (4), 1118\u20131132. https:\/\/doi.org\/10.1053\/j.gastro.2021.07.042 (2021).","journal-title":"Gastroenterology"},{"key":"31266_CR40","doi-asserted-by":"publisher","first-page":"104835","DOI":"10.1016\/j.phrs.2020.104835","volume":"158","author":"M -Leppkes","year":"2020","unstructured":"-Leppkes, M. & Neurath, M. F. Cytokines in inflammatory bowel diseases - Update 2020. Pharmacol. Res. 158, 104835. https:\/\/doi.org\/10.1016\/j.phrs.2020.104835 (2020).","journal-title":"Pharmacol. Res."},{"issue":"7","key":"31266_CR41","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1681\/ASN.2015070781","volume":"27","author":"O -Thaunat","year":"2016","unstructured":"-Thaunat, O., Koenig, A., Leibler, C. & Grimbert, P. Effect of immunosuppressive drugs on humoral allosensitization after kidney transplant. J. Am. Soc. Nephrol. 27 (7), 1890\u20131900. https:\/\/doi.org\/10.1681\/ASN.2015070781 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"31266_CR42","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41575-018-0084-8","volume":"16","author":"AR -Moschen","year":"2019","unstructured":"-Moschen, A. R., Tilg, H. & Raine, T. IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting. Nat. Rev. Gastroenterol. Hepatol. 16 (3), 185\u2013196. https:\/\/doi.org\/10.1038\/s41575-018-0084-8 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"6","key":"31266_CR43","doi-asserted-by":"publisher","first-page":"535","DOI":"10.4161\/mabs.3.6.17815","volume":"3","author":"JM -Benson","year":"2011","unstructured":"-Benson, J. M. et al. Discovery and mechanism of ustekinumab: a human monoclonal antibody targeting interleukin-12 and interleukin-23 for treatment of immune-mediated disorders. MAbs 3 (6), 535\u2013545. https:\/\/doi.org\/10.4161\/mabs.3.6.17815 (2011).","journal-title":"MAbs"},{"issue":"5","key":"31266_CR44","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1177\/1756283X10374216","volume":"3","author":"EJ -Scherl","year":"2010","unstructured":"-Scherl, E. J., Kumar, S. & Warren, R. U. Review of the safety and efficacy of ustekinumab. Th. Adv. Gastroenterol. 3 (5), 321\u2013328. https:\/\/doi.org\/10.1177\/1756283X10374216 (2010).","journal-title":"Th. Adv. Gastroenterol."},{"issue":"2","key":"31266_CR45","doi-asserted-by":"publisher","first-page":"150","DOI":"10.5603\/EP.2014.0021","volume":"65","author":"H -Miko\u015b","year":"2014","unstructured":"-Miko\u015b, H., Miko\u015b, M., Obara-Moszy\u0144ska, M. & Niedziela, M. The role of the immune system and cytokines involved in the pathogenesis of autoimmune thyroid disease (AITD). Endokrynol Pol. 65 (2), 150\u2013155. https:\/\/doi.org\/10.5603\/EP.2014.0021 (2014).","journal-title":"Endokrynol Pol."},{"key":"31266_CR46","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2147\/CEOR.S446560","volume":"16","author":"D Gogas Yavuz","year":"2024","unstructured":"Gogas Yavuz, D. et al. The economic impact of obesity in turkey: A Micro-Costing analysis. Clinicoecon Outcomes Res. 16, 123\u2013132. https:\/\/doi.org\/10.2147\/CEOR.S446560 (2024). Published 2024 Mar 5.","journal-title":"Clinicoecon Outcomes Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31266-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31266-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31266-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:04:02Z","timestamp":1768565042000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31266-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["31266"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-31266-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"24 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted in accordance with the 1964 Helsinki Declaration. The Ethics Committee of Istanbul University-Cerrahpa\u015fa approved the study (No: 602785). Trial registration was not applicable because the study did not prospectively assign individuals to a health-related intervention. The article was prepared in accordance with the Improving Quality and Transparency of Health Research (EQUATOR) Network guidelines for observational studies (STROBE).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Italic' removed-->Ethical statement"}},{"value":"Signed informed consent was obtained from all study participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"1682"}}